T1	SNP 34 50	genetic variants
T2	Entity 65 69	5p12
R1	SNP_location Arg1:T1 Arg2:T2	
T4	Cancer 103 116	breast cancer
T5	Spec 13 23	assessment
T6	Association 117 121	risk
E2	Association:T6 bc:T4 snp_int:T1
R2	Speculation_marker Arg1:E2 Arg2:T5	
T3	Entity 74 97	hormone receptor status
R3	Risk_Factor Arg1:T1 Arg2:T3	
T7	SNP 303 313	rs10941679
T8	SNP 315 324	rs4415084
T9	SNP 330 338	rs981782
T11	Entity 366 370	5p12
R4	SNP_location Arg1:T7 Arg2:T11	
R5	SNP_location Arg1:T8 Arg2:T11	
R6	SNP_location Arg1:T9 Arg2:T11	
T12	Association 380 390	implicated
E3	Association:T12 bc:T13 snp_int:T9 snp_int2:T8 snp_int3:T7
T13	Cancer 394 396	BC
T14	Spec 437 458	contradictory results
R7	Speculation_marker Arg1:E3 Arg2:T14	
T15	Level 637 650	significantly
T16	Effect_Type 651 659	elevated
T17	Association 663 667	risk
E4	Association:T17 bc:T18 snp_int:T19 snp_int2:T20 snp_int3:T21
T18	Cancer 660 662	BC
R8	Effect_type_marker Arg1:E4 Arg2:T16	
R9	Level_marker Arg1:E4 Arg2:T15	
A4	Effect_Type E4 Increase
A5	Level E4 High
T19	SNP 688 698	rs10941679
T20	SNP 700 709	rs4415084
T21	SNP 715 723	rs981782
T23	Entity 921 931	Caucasians
T24	Entity 936 947	East Asians
T25	Association 852 857	risks
E6	Association:T25 bc:T18 snp_int:T28 snp_int2:T33
A6	Effect_Type E6 Increase
A7	Level E6 High
T26	Level 828 841	significantly
T27	Effect_Type 842 851	increased
R10	Effect_type_marker Arg1:E6 Arg2:T27	
R11	Level_marker Arg1:E6 Arg2:T26	
T28	SNP 877 887	rs10941679
T29	SNP 892 901	rs4415084
T30	Association 970 982	associations
E7	Association:T30 bc:T18 snp_int:T32 snp_int2:T29
T31	Level 955 969	no significant
R12	Level_marker Arg1:E7 Arg2:T31	
A8	Level E7 Low
T32	SNP 877 887	rs10941679
T33	SNP 892 901	rs4415084
T10	Entity 1068 1072	5p12
T22	SNP 1073 1081	rs981782
T35	Association 1095 1107	associations
E5	Association:T35 snp_int:T22 bc:T37
A10	Level E5 High
T34	Level 1083 1094	significant
R13	Level_marker Arg1:E5 Arg2:T34	
R14	SNP_location Arg1:T22 Arg2:T10	
T36	Entity 1133 1143	Caucasians
R15	Population_assignment Arg1:T22 Arg2:T36	
T37	Cancer 1579 1581	BC
T38	SNP 1172 1182	rs10941679
T39	SNP 1187 1196	rs4415084
T40	Entity 1200 1204	5p12
T41	Association 1205 1216	confer risk
E1	Association:T41 snp_int:T38 snp_int2:T39 bc:T42
R16	SNP_location Arg1:T39 Arg2:T40	
R17	SNP_location Arg1:T38 Arg2:T40	
T42	Cancer 1234 1251;1257 1272	estrogen receptor positive tumors
T43	Entity 1253 1255	ER
A11	Cancer_Type T42 ER+
R19	Population_assignment Arg1:T28 Arg2:T23	
R20	Population_assignment Arg1:T28 Arg2:T24	
T44	Entity 1026 1033	African
T45	Entity 1038 1062	other ethnic populations
R21	Population_assignment Arg1:T32 Arg2:T44	
R22	Population_assignment Arg1:T32 Arg2:T45	
R23	Population_assignment Arg1:T33 Arg2:T23	
R24	Population_assignment Arg1:T33 Arg2:T24	
R25	Population_assignment Arg1:T29 Arg2:T44	
R26	Population_assignment Arg1:T29 Arg2:T45	
T46	Entity 1234 1251	estrogen receptor
T47	Organic_inorganic_molecules_affected 1205 1216	confer risk
E8	Organic_inorganic_molecules_affected:T47 Theme:T46 Agent:T38 Agent2:T39
T48	Effect_Type 1257 1265	positive
A12	Effect_Type E8 Increase
R27	Effect_type_marker Arg1:E8 Arg2:T48	
A1	SNP_Class T1 Common_variant
T49	Entity 724 735	risk allele
R29	SNP_allele Arg1:T21 Arg2:T49	
R30	Member Arg1:T1 Arg2:T28	
R31	Member Arg1:T1 Arg2:T33	
R32	Member Arg1:T1 Arg2:T22	
R28	Equiv Arg1:T13 Arg2:T4	
R18	Equiv Arg1:T43 Arg2:T46	
